Claritev (CTEV) Non Operating Investment Income (2020 - 2025)

Claritev's (CTEV) quarterly Non Operating Investment Income came in at -$2.7 million in Q3 2025, down 1022.84% quarter-over-quarter from $289000.0 in Q1 2022.

Claritev (CTEV) Non Operating Investment Income (2020 - 2025) Analysis & Trends

Claritev's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at -$2.7 million for Q3 2025.

  • On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to -$2.7 million in Q3 2025; TTM through Dec 2025 was -$2.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$2.7 million, changed N/A from the prior year.
  • Non Operating Investment Income declined to -$2.7 million in Q3 2025 per CTEV's latest filing, from $289000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $289000.0 in Q1 2022 and bottomed at -$2.7 million in Q3 2025.
  • The 3-year median for Non Operating Investment Income is $25000.0 (2021), against an average of -$784333.3.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Veeva Systems 31.66 Bn 24.35 Bn 662.02 Mn -
2 BrightSpring Health Services 14.67 Bn 13.77 Bn 482.22 Mn -
3 Healthequity 8.29 Bn 8.02 Bn 256.31 Mn -
4 Hinge Health 5.93 Bn 5.62 Bn 154.23 Mn -
5 10x Genomics 5.87 Bn 5.33 Bn 106.18 Mn -
6 MiniMed 4.49 Bn 4.19 Bn 480.00 Mn -
7 Waystar Holding 4.45 Bn 4.38 Bn 216.84 Mn -
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn -
9 Privia Health 3.18 Bn 2.76 Bn - -
10 Claritev 374.58 Mn 339.85 Mn 175.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -2.67 Mn
Sep 30, 2025 -2.67 Mn
Mar 31, 2022 289,000.00
Mar 31, 2022 289,000.00
Jun 30, 2021 25,000.00
Jun 30, 2021 25,000.00
Dec 31, 2020 -4.38 Mn
Dec 31, 2020 -4.38 Mn
Sep 30, 2020 -7.78 Mn
Sep 30, 2020 -7.78 Mn
Mar 31, 2020 2.23 Mn
Mar 31, 2020 2.23 Mn